Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

4% versus 2% in the longer term study.

> Although this is pure randomness with such close measurements.

That's not how this works at scale. We need larger studies, yes, but you can't simply dismiss a doubling of long-term symptom reports.

At population scale, even a 1-2% incidence means millions of people.



It is pretty weak though. There were only 109 seropositive kids in the follow-up according to the table, so you're talking about 2 more kids reporting a cough or headache as the entire basis of your concern.


There is no doubling here – only random noise.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: